Page 169 - Neuropsychiatric.indd
P. 169

60. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, et al. 2017
                   ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of

                   Heart Failure: A Report of the American College of Cardiology/American Heart Association
                   Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
                   Circulation. 2017;136(6):e137-e161.
               61. สมาคมแพทย์โรคหัวใจแห่งประเทศไทย. แนวทางเวชปฏิบัติเพื่อการวินิจฉัยและการดูแลรักษาผู้ป่วยภาวะ

                   หัวใจล้มเหลว พ.ศ.2562. สมุทรปราการ: ห้างหุ้นส่วนจ ากัด เนคสเตป ดีไซน์, 2562.
               62. Page RL, O'Bryant CL, Cheng D, Dow TJ, Ky B, Stein CM, et al. Drugs that may cause or
                   exacerbate heart failure: A scientific statement from the American Heart Association.

                   Circulation. 2016;134(6):e32-69.
               63. Al Hamarneh YN, Tsuyuki RT. Chapter 24 Heart failure. In: Tisdale JE et al., eds. Drug-
                   Induced  Diseases:  Prevention,  Detection, and  Management. 3rd  ed.  United  States:
                   American Society of Health-System Pharmacists, Inc., 2018
               64. Maxwell CB,  Jenkins AT. Drug-induced  heart failure. Am  J  Health  Syst  Pharm.

                   2011;68(19):1791-804.
               65. Smith LA, Cornelius VR, Plummer CJ, Levitt G, Verrill M, Canney P, et al. Cardiotoxicity of
                   anthracycline agents for the treatment of cancer: systematic review and meta-analysis of

                   randomised controlled trials. BMC Cancer. 2010;10:337.
               66. Ghatalia P, Morgan CJ, Je Y, Nguyen PL, Trinh QD, Choueiri TK, et al. Congestive heart failure
                   with vascular endothelial growth factor receptor tyrosine kinase inhibitors. Crit Rev Oncol
                   Hematol. 2015;94(2):228-37.

               67. Chatterjee S, Ghosh J, Lichstein E, Aikat S, Mukherjee D. Meta-analysis of cardiovascular
                   outcomes with dronedarone in patients with atrial fibrillation or heart failure. Am J
                   Cardiol. 2012;110(4):607-13.
               68. Loke YK, Kwok CS, Singh S. Comparative cardiovascular effects of thiazolidinediones:

                   systematic review and meta-analysis of observational studies. BMJ. 2011 Mar
                   17;342:d1309. doi: 10.1136/bmj.d1309.
               69. Verma  S,  Goldenberg  RM, Bhatt  DL,  Farkouh ME,  Quan  A,  Teoh H, et al. Dipeptidyl
                   peptidase-4 inhibitors and the risk of heart failure: a systematic review and meta-analysis.

                   CMAJ Open. 2017;5(1):E152-77.
               70. The American Diabetes Association. Standards of Medical Care in Diabetes-2016. Diabetes
                   Care. 2016;39(suppl 1):S1-S109.
               71. Pletal (cilostazol). Product information. [accessed 29 November 2020]. Available from:

                   https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020863s024lbl.pdf
               72. Lithium. Product information. [accessed 29 November 2020]. Available from: https://www.
                   accessdata.fda.gov/drugsatfda_docs/label/2018/017812s033,018421s032,018558s027lbl.p
                   df





                                                                                                       148
               148
   164   165   166   167   168   169   170   171   172   173   174